Position in ALT
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,756,224
+$370,769 QoQ
Shares Held
570,203
+48.6% QoQ
Ownership
0.293%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Derivatives in ALT
reported options exposure · as of Mar 31, 2023CallValue
$1,477,000
CallShares
350,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. ALT ranks #191 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ALT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,756,224 | 570,203 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,385,455 | 383,783 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,208,055 | 320,440 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,770,992 | 716,019 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,402,760 | 280,552 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,311,418 | 181,889 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $917,971 | 149,507 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,857,596 | 279,338 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,088,695 | 499,872 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $303,490 | 26,977 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $157,295 | 60,499 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $288,303 | 81,673 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,726,735 | 646,146 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $1,477,000 | 350,000 | Call | Defined | 2023-05-12 | |
| 2022-12-31 | $1,645,000 | 100,000 | Call | Defined | 2023-02-10 | |
| 2022-12-31 | $8,712,511 | 529,636 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,277,000 | 100,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $3,348,344 | 262,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $760,183 | 64,973 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $139,083 | 22,838 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,066,221 | 225,570 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,131 | 100 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $242,281 | 21,422 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $181,209 | 18,397 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $324,636 | 22,975 | Shares | Defined | 2021-05-14 | |
| 2020-06-30 | $3,237,622 | 302,299 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||